Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-04

Clinical Trial Update: DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women [Phase 3]

View source ↗

Summary

Phase 3 trial update on DTG plus 3TC as prophylaxis for preventing mother-to-child transmission of HIV during pregnancy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DTG plus 3TC

Snippet

Sponsor: Fundação Bahiana de Infectologia | Conditions: HIV Infections, Pregnancy Related | Phase 3 | Status: COMPLETED